Newsroom

Report: Prescription Drug Spending Tops Year-over-Year Price Growth for Selected Health Categories

“This latest health care price growth report indicates that spending on pricey prescription medications shows no sign of slowing down. When compared to other health care services, it is clear that high cost treatments continue to top the charts as a serious threat to the sustainability of our health care system and beyond.”

Read more

New effective medicines are of no use if they are unaffordable

The pharmaceutical industry have, in recent years, focused on development of so-called specialty drugs and have priced them aggressively. These prices, such as the US$1,000 per pill price for the hepatitis C drug sofosbuvir, are alarming for patients, employers, insurers, and governments.

Read more

New Cholesterol Drugs Are Vastly Overpriced, Analysis Says

Two powerful new drugs that can sharply lower cholesterol are vastly overpriced based on the value they provide, according to a new analysis by an independent organization that evaluates pharmaceutical costs.

Read more

The Price for Lowering Cholesterol

The hepatitis C drugs, which cured a vast majority of patients in clinical trials, are essentially a one-time cost. The cholesterol drugs, by contrast, will be taken for a lifetime. At these rates, the lifetime costs could be staggering.

Read more